|
PTPN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.19150245225796E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.39249999998282E-09 |
| Normal-vs-Stage2 |
6.771800E-04 |
| Normal-vs-Stage3 |
6.27229999999868E-05 |
| Normal-vs-Stage4 |
5.376200E-02 |
| Stage1-vs-Stage2 |
6.586200E-01 |
| Stage1-vs-Stage3 |
4.897800E-02 |
| Stage1-vs-Stage4 |
5.279600E-01 |
| Stage2-vs-Stage3 |
3.216000E-01 |
| Stage2-vs-Stage4 |
3.501200E-01 |
| Stage3-vs-Stage4 |
1.370250E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.41480160920082E-11 |
| Normal-vs-AfricanAmerican |
4.37600000000593E-05 |
| Normal-vs-Asian |
2.934800E-01 |
| Caucasian-vs-AfricanAmerican |
3.229600E-01 |
| Caucasian-vs-Asian |
5.108800E-01 |
| AfricanAmerican-vs-Asian |
7.708400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.75429670790095E-11 |
| Normal-vs-Female |
5.57090000019578E-07 |
| Male-vs-Female |
7.617600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.987700E-04 |
| Normal-vs-Extreme_Weight |
2.82240000037959E-07 |
| Normal-vs-Obese |
2.78470000392161E-08 |
| Normal-vs-Extreme_Obese |
4.785700E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.213400E-01 |
| Normal_Weight-vs-Obese |
8.115900E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.553800E-01 |
| Extreme_Weight-vs-Obese |
3.695400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.432400E-01 |
| Obese-vs-Extreme_Obese |
8.018000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.057700E-03 |
| Normal-vs-Age(41-60Yrs) |
2.36279884546775E-11 |
| Normal-vs-Age(61-80Yrs) |
1.78419999885548E-08 |
| Normal-vs-Age(81-100Yrs) |
9.557700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.335400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.954400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.101200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.074300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.070400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.819400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.13959952585674E-10 |
| Normal-VS-Type2 PRCC |
1.68506000000068E-05 |
| Normal-VS-KIRP CIMP |
1.378370E-02 |
| Normal-VS-Unclassified PRCC |
1.35910000031991E-07 |
| Type1 PRCC-VS-Type2 PRCC |
4.418400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.894800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.836800E-03 |
| Type2 PRCC-VS-KIRP CIMP |
5.272400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.645400E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
1.618470E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.23929999998429E-06 |
| Normal-vs-N1 |
3.989300E-04 |
| Normal-vs-N2 |
1.654640E-01 |
| N0-vs-N1 |
9.715000E-01 |
| N0-vs-N2 |
3.570000E-01 |
| N1-vs-N2 |
3.221400E-01 |
|
|
